Skip to content

Faricimab

Generic Medicine With 1 Brands Available In Bangladesh. Read What It Is For And How It Is Taken, Then Compare The Brands By Strength, Maker And Price.

Generic Guide

About Faricimab

What This Generic Is For, How It Is Taken, And What To Watch For.

Indications

Faricimab is a bispecific angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of: Neovascular (wet) age-related macular degeneration (nAMD) Diabetic macular edema (DME) Macular edema secondary to retinal vein occlusion (RVO)

Dosage And Administration

General: For intravitreal injection only. VABYSMO must be administered by a qualified physician experienced in intravitreal injections. Each vial should only be used for the treatment of a single eye. Neovascular (wet) age-related macular degeneration (nAMD): The recommended dose for VABYSMO is 6 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 4 doses, followed by 6 mg (0.05 mL) via intravitreal injection at a dosing interval of up to every 16 weeks (4 months). Monitoring between the dosing visits should be scheduled based on the patient's status and at the physician's discretion. Diabetic macular edema (DME): The recommended dose for VABYSMO is 6 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 4 doses, followed by 6 mg (0.05 mL) via intravitreal injection at intervals of up to every 16 weeks (4 months). Monitoring between the dosing visits should be scheduled based on the patient's status and at the physician's discretion. Macular edema secondary to retinal vein occlusion (RVO): The recommended dose for VABYSMO is 6 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly). Monitoring between the dosing visits should be scheduled based on the patient’s status and at the physician’s discretion.

Side Effects

This Information Is Not Available. Ask Your Doctor Or Pharmacist.

Precautions And Warnings

This Information Is Not Available. Ask Your Doctor Or Pharmacist.

Pregnancy And Lactation

There are no data from the use of Faricimab in pregnant women. It is not known whether Faricimab is excreted in human breast milk. No studies have been conducted to assess the impact of Faricimabon milk production or its presence in breast milk.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Clinical Details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Available Brand Names: 1

Sorted By
IV Injection

Vabysmo 6 mg/0.05 ml

Generic: Faricimab

103953.82Taka / 6 mg vial

View Medicine

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250